Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma, Acoustic × brigatinib × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 4 Neuroma, Acoustic 1 Neurofibromatosis 2 1 NSCLC 1 Meningioma 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1 Ependymoma 1 ALK-positive Advanced NSCLC 1 ALK+ Advanced NSCLC 1

Interventions

tozuleristide 1 neratinib 1 brigatinib 1 Sufentanil 1 Radiosurgery 1 Mn-PyC3A 1 Bevacizumab 1 Aspirin 1 AZD 6244 1 ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04374305 2026-01-12

INTUITT-NF2

Massachusetts General Hospital

Phase 2 Active not recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡